This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Hiroyuki Ito: Innovator in Irritable Bowel Syndrome Treatment
Introduction
Hiroyuki Ito is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of irritable bowel syndrome (IBS). His innovative approach has led to the development of a unique treatment that addresses this common gastrointestinal disorder.
Latest Patents
Hiroyuki Ito holds a patent for a treatment for irritable bowel syndrome, specifically for the compound N-(1H-tetrazol-5-yl)-1-phenoxy-4H-quinolizin-4-one-3-carboxamide. This compound has been shown to be effective in treating IBS. Furthermore, it may be used in conjunction with various serotonin 5-HT3 receptor antagonists to enhance its effectiveness.
Career Highlights
Hiroyuki Ito is currently associated with Astellas Pharma GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in advancing treatments for gastrointestinal disorders.
Collaborations
Hiroyuki Ito collaborates with esteemed colleagues, including Ryuichi Takezawa and Hitoshi Doihara. Their combined expertise contributes to the ongoing research and development efforts within their organization.
Conclusion
Hiroyuki Ito's work in developing treatments for irritable bowel syndrome showcases his commitment to improving patient outcomes. His innovative patent and collaboration with other professionals highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile